|
Real-time Estimate
Tradegate
23:15:56 17/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 360.78 EUR | +1.31% |
|
+0.74% | +28.43% |
| 11:30am | Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech | RE |
| 08-14 | Amgen Insider Sold Shares Worth $1,346,499, According to a Recent SEC Filing | MT |
| Market Cap | 224B 194B 182B 166B 312B 21,465B 317B 2,135B 835B 10,749B 843B 824B 35,720B | P/E 2026 * |
26.3x | P/E 2027 * | 23.5x |
|---|---|---|---|---|---|
| Enterprise Value | 266B 230B 216B 196B 369B 25,449B 375B 2,531B 990B 12,744B 999B 978B 42,351B | EV / Sales 2026 * |
6.84x | EV / Sales 2027 * | 6.51x |
| Free-Float |
99.78% | Yield 2026 * |
2.43% | Yield 2027 * | 2.57% |
Last Transcript: Amgen Inc.
| 1 day | +1.32% | ||
| 1 week | +0.74% | ||
| Current month | +8.21% | ||
| 1 month | +10.79% | ||
| 3 months | +29.94% | ||
| 6 months | +14.36% | ||
| Current year | +28.43% |
| 1 week | 355.7 |  | 364.1 |
| 1 month | 317.5 | | 364.1 |
| Current year | 271.8 | | 364.1 |
| 1 year | 230 | | 364.1 |
| 3 years | 230 | | 364.1 |
| 5 years | 174.58 | | 364.1 |
| 10 years | 120.65 | | 364.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.31% | +0.74% | - | - | 224B | |
| +1.03% | -3.31% | +70.65% | +121.55% | 1,052B | |
| +0.98% | +0.22% | +48.87% | +50.78% | 627B | |
| +0.61% | +0.96% | +21.19% | +66.87% | 441B | |
| +0.18% | -4.56% | +39.10% | +38.05% | 349B | |
| +0.57% | -2.90% | +22.85% | +37.01% | 287B | |
| +0.65% | -3.80% | -1.74% | +6.88% | 241B | |
| +0.69% | -0.09% | +42.44% | +57.97% | 224B | |
| -0.78% | -4.59% | -15.94% | -54.17% | 202B | |
| +0.25% | +4.19% | +17.49% | +81.22% | 172B | |
| Average | +0.55% | -0.77% | +27.21% | +45.13% | 399.46B | |
| Weighted average by Cap. | +0.72% | -0.63% | +39.89% | +64.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.89B 33.59B 31.56B 28.71B 53.97B 3,719B 54.86B 370B 145B 1,862B 146B 143B 6,188B | 40B 34.55B 32.47B 29.53B 55.51B 3,825B 56.43B 380B 149B 1,916B 150B 147B 6,366B |
| Net income | 8.6B 7.43B 6.98B 6.35B 11.93B 822B 12.13B 81.76B 31.97B 412B 32.28B 31.58B 1,368B | 9.39B 8.11B 7.62B 6.93B 13.04B 898B 13.25B 89.33B 34.93B 450B 35.27B 34.5B 1,495B |
| Net Debt | 41.67B 35.99B 33.82B 30.76B 57.82B 3,984B 58.78B 396B 155B 1,995B 156B 153B 6,631B | 36.01B 31.1B 29.23B 26.58B 49.98B 3,444B 50.8B 342B 134B 1,724B 135B 132B 5,731B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | €360.00 | +1.10% | 156 |
| 14/08/26 | €356.10 | -1.75% | 297 |
| 13/08/26 | €362.45 | +0.37% | 376 |
| 12/08/26 | €361.10 | +0.60% | 326 |
| 11/08/26 | €358.95 | +0.45% | 855 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
Select your edition
All financial news and data tailored to specific country editions
